Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packa ...
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Evrysdi™ (risdiplam)About 14,000
Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
Recall Date: Mar 18, 2021
Genentech has received 26 reports of leaking bottles. No injuries have been reported.
Genentech, a member of the Roche Group, of South San Francisco, Calif.
Recall ID: 9021
Last Published: Mar 18, 2021
Official Site: Link
RecallMe Number: 21729
RecallMe Status: Updated